AKT1 and colorectal carcinoma: Transcriptomic analysis revealed that PZH inhibited PI3K-Akt, interleukin-17, tumor necrosis factor, and cytokine-chemokine signaling by manipulating gut microbiota and metabolites, improving gut barrier function, and suppressing oncogenic and pro-inflammatory pathways, thereby inhibiting CRC carcinogenesis [57].